BioAmber Inc. (BIOA) has 51 open-market insider trades by 20 insiders since 2013. The most active filer is Kurt W. Briner, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Vijay Satyanand Pande | Dir | — | 2 | $24.9M | 2024-10-03 |
| James Healy | Dir | — | 1 | $12.0M | 2024-09-27 |
| Bihua Chen | — | — | 1 | $8.1M | 2024-09-27 |
| Patrick G. Enright | Dir | — | 1 | $7.2M | 2024-09-27 |
| Kurt W. Briner | Dir | — | 11 | $910K | 2017-08-15 |
| Dov A. Goldstein M.D. | CFO | — | 1 | $532K | 2026-04-23 |
| Jean-Francois Huc | Pres | — | 7 | $457K | 2016-05-11 |
| Michael A. Hartmann | PresVP | — | 8 | $280K | 2017-08-18 |
| Kenneth W. Wall | Dir | — | 6 | $254K | 2017-11-30 |
| Paul D. Rubin | — | — | 2 | $246K | 2026-04-01 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Shane Barton | CAO | Sell | $1.6M | 2026-06-29 |
| Paul D. Rubin | — | Sell | $157K | 2026-04-01 |
| Paul D. Rubin | — | Sell | $151K | 2026-03-02 |
| Paul D. Rubin | Chief Medical Officer | Sell | $139K | 2026-02-02 |
| Kristen Fortney | CEO | Sell | $4.2M | 2026-01-13 |
| Dov A. Goldstein M.D. | CFO | Sell | $532K | 2026-01-13 |
Companies that share insiders with BIOA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Paul D. Rubin | — | Sell | $95K | 2026-01-02 |
| Paul D. Rubin | — | Sell | $216K | 2025-12-09 |
| Paul D. Rubin | — | Sell | $1.4M | 2025-12-04 |
| Vijay Satyanand Pande | Director | Buy | $8.7M | 2024-10-01 |
| James Healy | Director | Buy | $12.0M | 2024-09-27 |
| Vijay Satyanand Pande | Director | Buy | $16.2M | 2024-09-27 |
| Shane Barton | Principal Accounting Officer | Buy | $47K | 2024-09-27 |
| Bihua Chen | — | Buy | $8.1M | 2024-09-27 |
| Rekha Hemrajani | Director | Buy | $54K | 2024-09-27 |